Multitargeted tyrosine kinase inhibition with crizotinib has been shown useful in a rare paediatric case of unresectable GOPC-ROS1 fusion agminated Spitz naevus. The Australian case, published in JAMA Dermatology, was a female who first presented as an infant with progressive facial lesions consistent with Spitz naevus. Following excision of the larger lesions, smaller lesions enlarged ...
Australian precision medicine success for Spitz naevus
By Mardi Chapman
16 Jun 2021